Page URL:

Trial of stem-cell therapy in the womb to begin

19 October 2015
Appeared in BioNews 824

Researchers have announced the first clinical trial of stem-cell therapy for fetuses still in the womb, as a treatment for brittle bone disease.

The trial team, led by the Karolinska Institutet in Stockholm, Sweden, has previously treated two children before birth with stem cells that target fractures in bones and help produce collagen.

'The oldest child to have received the treatment is now 13 and is performing better than expected and is still growing,' said Dr Cecilia Götherström, lead researcher on the trial. 'But we believe that we can improve the treatment for other patients by administering it to the unborn baby and again in repeated doses during the child's first years of life.'

Babies with Osteogenesis Imperfecta, which is caused by a mutation in the gene that produces collagen, are born with multiple fractures and are vulnerable to repeated bone fractures and growth problems throughout life. The disease can ultimately be fatal. Signs of the condition can be detected on antenatal ultrasound scans and it can be confirmed by genetic testing.

The trial, called BOOSTB4 ('Boost Brittle Bones Before Birth'), aims to involve 30 children with the condition; fifteen will be given the stem-cell treatment before birth and in the first few years of life and fifteen will be given the treatment only after birth. The number of fractures in both groups will be compared to determine whether in-utero stem-cell therapy is more effective than treatment after birth alone. The stem cells will be obtained from donated aborted fetuses.

Researchers have previously trialled the method in mice, with good results, but this is the first trial of its kind in humans. 'In preclinical mouse studies [the stem cells] honed to the site of bone fractures and improved the bone healing,' Dr Anna David, one of the collaborators from University College London, told BioNews.

Dr Dusko Ilic, a researcher from King's College London who is not involved in the trial, told BBC News that he welcomed the trial but cautioned that it could be difficult to interpret the results: 'How will we know whether a milder phenotype in a child that received the treatment is natural or is a result of the treatment?'

Dr David explained that the current trial will principally determine whether the treatment is safe. If it is then it would be followed by a full-scale randomised trial. If successful, the researchers hope it will lead the way to stem-cell therapies for other severe prenatal diseases, such as Duchenne muscular dystrophy or thalassaemia. 'This is a major step for fetal therapy for congenital disease,' she told BioNews.

Europe-wide project launched that uses stem cells to treat brittle bone disease in the womb
GOSH (press release) |  12 October 2015
First clinical trial to strengthen babies bones in the womb
The Telegraph |  12 October 2015
First 'in womb' stem cell trial to begin
BBC News |  12 October 2015
Researchers Are Giving Stem Cell Therapy To Babies Before They’re Born
BuzzFeed |  14 October 2015
Stem cell study to help fight brittle-bone disease
Leicester University (press release) |  12 October 2015
4 June 2018 - by Dr Nicoletta Charolidi 
The first in utero stem cell transplant trial has welcomed its first baby - born after being treated in the womb with her mother's stem cells...
16 November 2015 - by Dr Jane Currie 
Tomcat is a play set in a future where state-controlled prenatal screening has eradicated all genetic conditions. Nearly all, that is...
5 October 2015 - by Jenny Sharpe 
A potential treatment for wet age-related macular degeneration has been carried out for the first time...
10 August 2015 - by Rebecca Carr 
Fetal stem cell research in the USA has come under the spotlight after an undercover video was released of an official from Planned Parenthood discussing how fetal organs are being used in research...
20 July 2015 - by Dr Julia Hill 
Scientists in the USA have demonstrated how stem cell techniques may benefit people with incurable mitochondrial diseases. The research suggests it might be possible one day to replace diseased tissue in patients affected by the disorders...
1 December 2014 - by Dr Ainsley Newson 
Geneticist Razib Khan's decision to obtain the whole genome sequence of his partner's fetus in utero shows us that genomics is no longer a fantasy. While it would be a mistake to use this one example to condemn the entire practice of whole genome sequencing prior to birth, I will suggest here why we should look before we leap...
6 April 2004 - by Dr Jess Buxton 
Doctors may one day be able to use gene therapy to treat fetuses affected by genetic conditions, say UK scientists. Researchers at Imperial College, University College and the Royal Free Hospital, all in London, have successfully used gene therapy to treat unborn mice affected by haemophilia B. Simon Waddington, of...
to add a Comment.

By posting a comment you agree to abide by the BioNews terms and conditions

Syndicate this story - click here to enquire about using this story.